Evidence map›Paper›PMID 29077761›Full record

ArticlePLoS pathogens2017

In vitro characterization of the antivirulence target of Gram-positive pathogens, peptidoglycan O-acetyltransferase A (OatA).

David Sychantha, Carys S Jones, Dustin J Little, Patrick J Moynihan, Howard Robinson, Nicola F Galley, David I Roper, Christopher G Dowson, P Lynne Howell, Anthony J Clarke

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Mechanism ofProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  13. Bacteria and Host Interplay inPathogens (Basel, Switzerland) · 2021
    Review
  14. Article
  15. Article
  16. Structural basis for theThe Journal of biological chemistry · 2020
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

David SychanthaDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
Carys S JonesDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
Dustin J LittleProgram in Molecular Structure and Function, Research Institute, The Hospital for Sick Children, Toronto ON, Canada.
Patrick J MoynihanSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.ORCID http://orcid.org/0000-0003-4182-6223
Howard RobinsonPhoton Science Division, Brookhaven National Laboratory, Upton, New York, United States of America.ORCID http://orcid.org/0000-0001-7523-4678
Nicola F GalleySchool of Life Sciences, University of Warwick, Coventry, United Kingdom.ORCID http://orcid.org/0000-0001-7630-2601
David I RoperSchool of Life Sciences, University of Warwick, Coventry, United Kingdom.ORCID http://orcid.org/0000-0003-0009-621X
Christopher G DowsonSchool of Life Sciences, University of Warwick, Coventry, United Kingdom.ORCID http://orcid.org/0000-0002-8294-8836
P Lynne HowellProgram in Molecular Structure and Function, Research Institute, The Hospital for Sick Children, Toronto ON, Canada.
Anthony J ClarkeDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.ORCID http://orcid.org/0000-0003-4076-0488
University of Guelph · CAUniversity of Warwick · GBUniversity of Toronto · CABrookhaven National Laboratory · USUniversity of Birmingham · GB

Funding

Medical Research Council MR/N002679/1
6 · The paper itself

Abstract

The O-acetylation of the essential cell wall polymer peptidoglycan occurs in most Gram-positive bacterial pathogens, including species of Staphylococcus, Streptococcus and Enterococcus. This modification to peptidoglycan protects these pathogens from the lytic action of the lysozymes of innate immunity systems and, as such, is recognized as a virulence factor. The key enzyme involved, peptidoglycan O-acetyltransferase A (OatA) represents a particular challenge to biochemical study since it is a membrane associated protein whose substrate is the insoluble peptidoglycan cell wall polymer. OatA is predicted to be bimodular, being comprised of an N-terminal integral membrane domain linked to a C-terminal extracytoplasmic domain. We present herein the first biochemical and kinetic characterization of the C-terminal catalytic domain of OatA from two important human pathogens, Staphylococcus aureus and Streptococcus pneumoniae. Using both pseudosubstrates and novel biosynthetically-prepared peptidoglycan polymers, we characterized distinct substrate specificities for the two enzymes. In addition, the high resolution crystal structure of the C-terminal domain reveals an SGNH/GDSL-like hydrolase fold with a catalytic triad of amino acids but with a non-canonical oxyanion hole structure. Site-specific replacements confirmed the identity of the catalytic and oxyanion hole residues. A model is presented for the O-acetylation of peptidoglycan whereby the translocation of acetyl groups from a cytoplasmic source across the cytoplasmic membrane is catalyzed by the N-terminal domain of OatA for their transfer to peptidoglycan by its C-terminal domain. This study on the structure-function relationship of OatA provides a molecular and mechanistic understanding of this bacterial resistance mechanism opening the prospect for novel chemotherapeutic exploration to enhance innate immunity protection against Gram-positive pathogens.

Indexed as

AcetyltransferasesBacterial ProteinsCell WallDrug ResistanceGram-Positive BacteriaHumansPeptidoglycanStaphylococcus aureusSubstrate SpecificityVirulenceVirulence FactorsAcetyltransferasesBacterial ProteinsPeptidoglycanVirulence Factors

Identifiers

PMID29077761
PMCPMC5697884
OpenAlexW2765799080

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.